Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
0
mi
from 98109
Seattle, WA
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
0
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
226
mi
from 98109
Spokane, WA
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
226
mi
from 98109
Spokane, WA
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
95
mi
from 98109
Wenatchee, WA
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
95
mi
from 98109
Wenatchee, WA
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
2127
mi
from 98109
Charleston, WV
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
2127
mi
from 98109
Charleston, WV
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
2087
mi
from 98109
Huntington, WV
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
2087
mi
from 98109
Huntington, WV
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
1615
mi
from 98109
Madison, WI
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
1615
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
1687
mi
from 98109
Milwaukee, WI
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
1622
mi
from 98109
Oregon, WI
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
1622
mi
from 98109
Oregon, WI
Click here to add this to my saved trials
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  11/27/2017
GSK Investigational Site
5366
mi
from 98109
Vienna,
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Randomized, Double-Blind Study to Compare the Durability of Glucose Lowering and Preservation of Pancreatic Beta-Cell Function of Rosiglitazone Monotherapy Compared to Metformin or Glyburide/Glibenclamide in Patients With Drug-Naive, Recently Diagnosed Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 11/27/2017
GSK Investigational Site
5366
mi
from 98109
Vienna,
Click here to add this to my saved trials
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
A Multi-Center, Prospective, Randomized Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
HyperbaRXs
2171
mi
from 98109
Cumming, GA
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
A Multi-Center, Prospective, Randomized Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
HyperbaRXs
2171
mi
from 98109
Cumming, GA
Click here to add this to my saved trials
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
A Multi-Center, Prospective, Randomized Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Covenant Medical Center
1860
mi
from 98109
Saginaw, MI
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
A Multi-Center, Prospective, Randomized Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Covenant Medical Center
1860
mi
from 98109
Saginaw, MI
Click here to add this to my saved trials
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
A Multi-Center, Prospective, Randomized Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Professional Hospital
3729
mi
from 98109
Guaynabo,
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
A Multi-Center, Prospective, Randomized Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Professional Hospital
3729
mi
from 98109
Guaynabo,
Click here to add this to my saved trials
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
A Randomized, Double-Blind Placebo-controlled Study Evaluating the Efficacy of Omega 3 Fatty Acid Augmentation of Desvenlafaxine for the Treatment of Major Depressive Disorder in Patients With Medical Illness.
Status: Enrolling
Updated:  11/30/2017
University of Connecticut Health Center
2424
mi
from 98109
Farmington, CT
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
A Randomized, Double-Blind Placebo-controlled Study Evaluating the Efficacy of Omega 3 Fatty Acid Augmentation of Desvenlafaxine for the Treatment of Major Depressive Disorder in Patients With Medical Illness.
Status: Enrolling
Updated: 11/30/2017
University of Connecticut Health Center
2424
mi
from 98109
Farmington, CT
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Associated Foot & Ankle Specialists, LLC
1111
mi
from 98109
Phoenix, AZ
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Associated Foot & Ankle Specialists, LLC
1111
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Center for Clinical Research
686
mi
from 98109
Castro Valley, CA
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Center for Clinical Research
686
mi
from 98109
Castro Valley, CA
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Pacific Wound Center
669
mi
from 98109
Stockton, CA
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Pacific Wound Center
669
mi
from 98109
Stockton, CA
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
First Coast Cardiovascular Institute
2457
mi
from 98109
Jacksonville, FL
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
First Coast Cardiovascular Institute
2457
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Beth Israel Deaconess Hospital-Plymouth
2519
mi
from 98109
Plymouth, MA
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Beth Israel Deaconess Hospital-Plymouth
2519
mi
from 98109
Plymouth, MA
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Duke University
2341
mi
from 98109
Durham, NC
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Duke University
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Wayne Memorial Hospital
2407
mi
from 98109
Goldsboro, NC
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Wayne Memorial Hospital
2407
mi
from 98109
Goldsboro, NC
Click here to add this to my saved trials
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  11/30/2017
Barry University Clinical Research
2725
mi
from 98109
North Miami Beach, FL
Phase IV Study to Evaluate the Efficacy of AMNIOEXCEL in Diabetic Foot Ulcers
A Multicenter, Prospective, Randomized, Parallel-group, Standard of Care-controlled Clinical Trial to Evaluate the Use of AMNIOEXCEL® in the Management of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 11/30/2017
Barry University Clinical Research
2725
mi
from 98109
North Miami Beach, FL
Click here to add this to my saved trials
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
Status: Enrolling
Updated:  12/3/2017
Ohio State University
2006
mi
from 98109
Columbus, OH
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
Intensive Glycemic Control for Congestive Heart Failure Exacerbation
Status: Enrolling
Updated: 12/3/2017
Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Comparative Study of Implant Surfaces to Enhance Stabilization in Patients With Type 2 Diabetes
A Randomized, Controlled Trial Comparing the Stability of SLA Implants and SLActive Implants Using Resonance Frequency Analysis for Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/4/2017
University of Texas Health Science Center at San Antonio
1780
mi
from 98109
San Antonio, TX
Comparative Study of Implant Surfaces to Enhance Stabilization in Patients With Type 2 Diabetes
A Randomized, Controlled Trial Comparing the Stability of SLA Implants and SLActive Implants Using Resonance Frequency Analysis for Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/4/2017
University of Texas Health Science Center at San Antonio
1780
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management on High-Risk Pregnancy Outcomes
Status: Enrolling
Updated:  12/5/2017
Johns Hopkins Medical Institutions
2329
mi
from 98109
Baltimore, MD
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management on High-Risk Pregnancy Outcomes
Status: Enrolling
Updated: 12/5/2017
Johns Hopkins Medical Institutions
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Point-of-Care Glucose Testing and Insulin Supplementation
Benefits of Point-of-Care Glucose Testing and Insulin Supplementation at Bedtime in Insulin Treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/5/2017
Emory University Hospital
2180
mi
from 98109
Atlanta, GA
Point-of-Care Glucose Testing and Insulin Supplementation
Benefits of Point-of-Care Glucose Testing and Insulin Supplementation at Bedtime in Insulin Treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/5/2017
Emory University Hospital
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Point-of-Care Glucose Testing and Insulin Supplementation
Benefits of Point-of-Care Glucose Testing and Insulin Supplementation at Bedtime in Insulin Treated Patients With Type 2 Diabetes
Status: Enrolling
Updated:  12/5/2017
Grady Memorial Hospital
2178
mi
from 98109
Atlanta, GA
Point-of-Care Glucose Testing and Insulin Supplementation
Benefits of Point-of-Care Glucose Testing and Insulin Supplementation at Bedtime in Insulin Treated Patients With Type 2 Diabetes
Status: Enrolling
Updated: 12/5/2017
Grady Memorial Hospital
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
Comparative Study of the Antithrombotic Effects of Ticagrelor and Clopidogrel in Type 2 Diabetic Patients
Status: Enrolling
Updated:  12/5/2017
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
Comparative Study of the Antithrombotic Effects of Ticagrelor and Clopidogrel in Type 2 Diabetic Patients
Status: Enrolling
Updated: 12/5/2017
Icahn School of Medicine at Mount Sinai
mi
from 98109
New York, NY
Click here to add this to my saved trials
Motivation Psychology-based Smart Engagement System
Motivation Psychology-based Smart Engagement System for Improved Older Adult Chronic Disease Management
Status: Enrolling
Updated:  12/5/2017
Baltimore VA Maryland Health Care System
2328
mi
from 98109
Baltimore, MD
Motivation Psychology-based Smart Engagement System
Motivation Psychology-based Smart Engagement System for Improved Older Adult Chronic Disease Management
Status: Enrolling
Updated: 12/5/2017
Baltimore VA Maryland Health Care System
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2083
mi
from 98109
Vestavia Hills, AL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2083
mi
from 98109
Vestavia Hills, AL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
1104
mi
from 98109
Peoria, AZ
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
1104
mi
from 98109
Peoria, AZ
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
1806
mi
from 98109
Jonesboro, AR
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
1806
mi
from 98109
Jonesboro, AR
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
663
mi
from 98109
Concord, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
663
mi
from 98109
Concord, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
977
mi
from 98109
Long Beach, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
977
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
956
mi
from 98109
Los Angeles, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
956
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
945
mi
from 98109
Mission Hills, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
945
mi
from 98109
Mission Hills, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
656
mi
from 98109
Spring Valley, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
656
mi
from 98109
Spring Valley, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
988
mi
from 98109
Tustin, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
988
mi
from 98109
Tustin, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
1013
mi
from 98109
Arvada, CO
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
1013
mi
from 98109
Arvada, CO
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2501
mi
from 98109
Brooksville, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2501
mi
from 98109
Brooksville, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2512
mi
from 98109
Clearwater, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2512
mi
from 98109
Clearwater, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2722
mi
from 98109
Hollywood, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2722
mi
from 98109
Hollywood, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2557
mi
from 98109
Kissimmee, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2557
mi
from 98109
Kissimmee, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2712
mi
from 98109
Plantation, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2712
mi
from 98109
Plantation, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2522
mi
from 98109
Tampa, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2522
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2179
mi
from 98109
Atlanta, GA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2179
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2207
mi
from 98109
Columbus, GA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2207
mi
from 98109
Columbus, GA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2168
mi
from 98109
Roswell, GA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2168
mi
from 98109
Roswell, GA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
2679
mi
from 98109
Honolulu, HI
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
2679
mi
from 98109
Honolulu, HI
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
396
mi
from 98109
Meridian, ID
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
396
mi
from 98109
Meridian, ID
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
1733
mi
from 98109
Chicago, IL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials